Genetic variants in mannose receptor gene (MRC1) confer susceptibility to increased risk of sarcoidosis

Sarcoidosis is a multi-organ inflammatory disease with exaggerated cellular immune activity that leads to formation of non-caseating granulomas in the affected organs. Although the causes of sarcoidosis remain unclear, several lines of evidence support the idea that sarcoidosis results from exposure of genetically susceptible individuals to unknown environmental triggers [1‐9]. Amomg this evidence, environmental pathogens such as Mycobacterium and Propionibacterium species have been suggested to play roles in the pathogenesis of sarcoidosis [7‐9]. Recent insights into the complex mechanisms underlying human innate immunity suggest that genetic variability in the genes encoding immune system components plays a role in the development of chronic inflammatory diseases. In particular, the association between sarcoidosis and genetic variants of several pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), have been extensively analyzed [10‐12]. Although TLRs are an important system for microbial sensing, they are not the only PRRs with this function. At the cell-surface, C-type lectin-like molecules, such as the mannose receptor and the β-glucan receptors, also participate in the binding and uptake of microbial components [13, 14]. Components of bacteria and viruses that gain entry into the cytoplasm are recognized by cytosolic receptors, through which they induce cytokine production and cell activation [15, 16]. Recent studies have shown the genetic association between sarcoidosis and non-TLRs [11, 17]. Mannose receptor (MR) is a member of the pattern-recognition C-type lectin receptor (CLR) family, which plays an important role in innate immunity. MR is predominantly present on macrophages and dendritic cells and recognizes glycan structures containing mannose, fucose and N-acetylglucosamine, which are commonly found on the cell walls of pathogenic micro-organisms such as mycobacteria, fungus, parasites and yeast [18]. We therefore speculated that the MRC1 gene may be an excellent candidate for susceptibility to sarcoidosis, and tested for associations between MRC1 polymorphisms and the development of sarcoidosis in our Japanese case-control analysis.

Demographic characteristics of the 424 healthy controls and 181 subjects with sarcoidosis from this population are listed in Table 2. Median age was significantly higher for subjects with sarcoidosis than for healthy control subjects (P < 0.05). The sarcoidosis group included significantly more females than the control group (P < 0.05). Pair-wise LD values for 7 SNPs are shown in Figure 1. No significant deviation from the Hardy-Weinberg equilibrium was observed in healthy control subjects (P > 0.05). Genotype and allele frequencies and counts for each SNP in the MRC1 gene are shown in Table 3. When we performed logistic repression analysis using a recessive model adjusted for age and gender, 3 SNPs tended to be associated with sarcoidosis (rs2477637, OR 1.76, 95%CI, 1.09-2.84, P = 0.02; rs692527, OR 1.58, 95%CI 1.02-2.46, P = 0.042; and rs691005, OR 2.53, 95%CI 1.47-4.37, P = 0.001; Table 4). Additional association was observed for SNP rs2253120 (OR 1.62, 95%CI 1.12-2.36, P = 0.011), when analysis was performed under a dominant model. The rs691005 SNP remained statistically significant after Bonferroni correction. The linkage disequilibrium map constructed from 7 SNPs is shown in Figure 1, as measured by D prime and we identified two haplotype blocks. Haplotype block 1 comprised two SNPs (rs2477631 and rs2477664), and haplotype block 2 comprised two SNPs (rs692527 and rs1926736). However, significant association was not found in haplotype analysis (Table 5).

Based on LD structure and significant association of rs691005 for initial analysis, we further genotyped two additional SNPs (rs554995 and rs554313) close to rs691005. Unfortunately, these two SNPs did not show significant associations (Tables 3 and 4). Although three SNPs (rs554995, rs554313 and rs691005) showed strong LD, significant associations were not found in haplotype analysis (Table 5).

In the present study we demonstrated the association between MRC1 polymorphisms and risk of sarcoidosis in Japanese population. In support of this, the association of one SNP (rs691005) was confirmed considering for multiple testing and Bonferroni correction, suggesting MRC1 gene as a plausible candidate gene for development of sarcoidosis. Of interest, recent genome-wide association analyses have shown that 10p12, where MRC1 is situated, is a susceptibility locus for the development of sarcoidosis [22]. Thus, findings of the current study suggest that MRC1 gene variants may contribute to the development of sarcoidosis.

The rs691005 located within the 3'-untranslated region (3'-UTR) of MRC1 showed the strongest association (OR 2.53). Although the real functions of this gene are unclear, variants in the 3'-UTR are known to disrupt a regulatory binding sequence and alter mRNA expression [23]. Alternatively, this variant may be representative of the region or correlated with a true functional variant. Thus, our current results provide a basis for further identification of the causative variants underlying the relationship between MRC1 gene sequences and sarcoidosis.

It should be noted that SNPs with two positions were mapped to MRC1 spanning chr10:17,891,368-17,993,183 (HapMap Data Rel 27) and were referred to by their MRC1L1 'rs'numbers (NCBI EntrezSNP database Build 130). Alter et al reported no evidence for a common gene duplication event [24]. The authors suggested that MRC1L is an erroneous annotation caused by the presence of a sequence gap and the incorrect assignment of a polymorphic haplotype.

We also reported the association of MRC1 gene polymorphism and risk of asthma in two independent ethnically diverse populations [19], suggesting that MRC1 might be involved in the pathogenesis of a number of chronic inflammatory diseases. Several reports have shown that genetic variants of genes related to PRRs such as TLR4 and CD14 are associated with susceptibility to both diseases [10, 11, 25‐27]. The present study adds further evidence supporting the involvement of macrophage PRRs in the development of sarcoidosis as a chronic inflammatory lung disease.

Of the SNPs examined, three SNPs (rs26777637, rs2253120 and rs692427) showed tendency for association with sarcoidosis (P = 0.02, P = 0.011, P = 0.042), but this association did not reach significance after the Bonferroni correction. However, associations of rs691005 remained significant even after Bonferroni correction (P = 0.001). In addition, power calculations based on study subjects of 181 cases and 424 controls, OR of 2.53 showed a sufficient genetic power (0.81) at the level of significance of 0.005. As the sample size of this study is not sufficiently large and is restricted to Japanese population, the present data should be validated in larger samples and in other ethnic groups.

This study suggests that the MRC1 gene may represent an important susceptibility locus for sarcoidosis at chromosome 10p12 and genetic variants in MRC1 may play significant roles in the pathogenesis of sarcoidosis. Importantly, the association we observed between MRC1 polymorphisms and sarcoidosis adds further evidence for the involvement of macrophage PRRs in the development of a number of chronic inflammatory diseases, including sarcoidosis. However, further studies are clearly needed to achieve a comprehensive coverage of genetic variants in and around the MRC1 gene, in order to identify causal variants conferring susceptibility to an increased risk of sarcoidosis.